Weiqi Xu

机构：Nanjing Agricultural University, Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center · ORCID：0000-0002-4259-0091

发表论文 109 篇 · 总被引 4131 次 · h-index 36

代表论文

• Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti–PD-1 resistance in hepatocellular carcinoma (2025 · Science Immunology · 被引 40)
• Effects of reaction temperature, pH and duration on conversion of tea catechins and formation of theaflavins and theasinensins (2023 · Food Bioscience · 被引 29)
• Anti-diabetic effect of dicaffeoylquinic acids is associated with the modulation of gut microbiota and bile acid metabolism (2024 · Journal of Advanced Research · 被引 27)
• TRIM14 Overexpression Induces Chemoresistance and Malignant Behaviors of Hepatocellular Carcinoma Cells by Activating the STAT3/HIF-1α Pathway (2023 · International Journal of Molecular Sciences · 被引 16)
• Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway (2023 · Hepatology International · 被引 15)
• Organoid modeling identifies USP3-AS1 as a novel promoter in colorectal cancer liver metastasis through increasing glucose-driven histone lactylation (2025 · Acta Pharmacologica Sinica · 被引 7)